• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

低氧饱和度-距离比:评估肺间质疾病功能的新概念。

Desaturation - distance ratio: a new concept for a functional assessment of interstitial lung diseases.

机构信息

Heart Institute, Universidade de São Paulo, SP, Brazil.

出版信息

Clinics (Sao Paulo). 2010;65(9):841-6. doi: 10.1590/s1807-59322010000900005.

DOI:10.1590/s1807-59322010000900005
PMID:21049210
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2954734/
Abstract

INTRODUCTION

The functional evaluation has become increasingly important in the understanding and management of patients with interstitial lung diseases. The cardiopulmonary exercise test and the six-minute walk test (6MWT), through their isolated variables, have been used to do this evaluation, with some limitations.

OBJECTIVES

We proposed a new composite index (desaturation distance ratio using continuous peripheral oxygen saturation (SpO₂) and the distance walked as a more reliable tool for doing a functional evaluation of these patients.

METHODS

6MWT was performed by interstitial lung diseases patients and controls. Analyzed parameters were walked distance and desaturation area (DAO₂), obtained by taking the difference between maximal SpO₂ possible (100%) and patient's SpO₂ every 2 seconds. desaturation distance ratio was calculated using the ratio between DAO₂ and distance walked.

RESULTS

Forty-nine interstitial lung diseases patients and 11 control subjects completed the protocol. The mean (SD) age was 60 (12) years and 65 (9) years, respectively (p:NS). Data obtained from 6MWT showed a significant statistical difference between interstitial lung diseases patients and controls: mean walked distance (430 and 602 meters, respectively); SpO₂ minimal maintained at least 10 seconds - SpO₂ min (85% and 94%, respectively), and median desaturation distance ratio (10 and 2.5, respectively). A correlation analysis, considering interstitial lung diseases patients, revealed the best correlation between desaturation distance ratio and DLco (r= - 0.72; p<0.001), being the correlation between SpO₂ min and DLco of 0.61 (p<0.001) and among walked distance and DLco of 0.58 (p<0.05).

CONCLUSION

Desaturation distance ratio is a promising concept and a more reliable physiologic tool to assess pulmonary diseases characterized by involvement of the alveolar-capillary membrane, such as interstitial lung diseases.

摘要

简介

在理解和管理间质性肺疾病患者时,功能评估变得越来越重要。心肺运动试验和六分钟步行试验(6MWT)通过其孤立的变量被用于进行这种评估,但存在一些局限性。

目的

我们提出了一个新的综合指数(使用连续外周血氧饱和度(SpO₂)和距离的饱和度下降距离比),作为评估这些患者功能的更可靠工具。

方法

对间质性肺疾病患者和对照组进行 6MWT。分析的参数为步行距离和饱和度下降面积(DAO₂),通过在每 2 秒时从最大可能的 SpO₂(100%)中减去患者的 SpO₂来获得。饱和度下降距离比是通过 DAO₂与步行距离的比值来计算的。

结果

49 名间质性肺疾病患者和 11 名对照组完成了方案。平均(SD)年龄分别为 60(12)岁和 65(9)岁(p:无统计学意义)。6MWT 获得的数据显示,间质性肺疾病患者和对照组之间存在显著的统计学差异:平均步行距离(分别为 430 米和 602 米);SpO₂最低维持至少 10 秒 - SpO₂ min(分别为 85%和 94%),以及中位数饱和度下降距离比(分别为 10 和 2.5)。考虑到间质性肺疾病患者的相关性分析显示,饱和度下降距离比与 DLco 的相关性最好(r=-0.72;p<0.001),SpO₂ min 与 DLco 的相关性为 0.61(p<0.001),步行距离与 DLco 的相关性为 0.58(p<0.05)。

结论

饱和度下降距离比是一种很有前途的概念,也是评估肺泡毛细血管膜受累的间质性肺疾病等肺部疾病的更可靠的生理工具。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6b90/2954734/a8b0f58b0934/cln-65-09-841-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6b90/2954734/3b9d4171ffc6/cln-65-09-841-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6b90/2954734/a8b0f58b0934/cln-65-09-841-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6b90/2954734/3b9d4171ffc6/cln-65-09-841-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6b90/2954734/a8b0f58b0934/cln-65-09-841-g002.jpg

相似文献

1
Desaturation - distance ratio: a new concept for a functional assessment of interstitial lung diseases.低氧饱和度-距离比:评估肺间质疾病功能的新概念。
Clinics (Sao Paulo). 2010;65(9):841-6. doi: 10.1590/s1807-59322010000900005.
2
Performance capacity evaluated using the 6-minute walk test: 5-year results in patients with diffuse systemic sclerosis and initial interstitial lung disease.使用6分钟步行试验评估的运动能力:弥漫性系统性硬化症和初始间质性肺病患者的5年结果。
Clin Exp Rheumatol. 2015 Jul-Aug;33(4 Suppl 91):S142-7. Epub 2015 Sep 1.
3
Relationship between outcome measures of six-minute walk test and baseline lung function in patients with interstitial lung disease.间质性肺疾病患者六分钟步行试验结果指标与基线肺功能的关系。
Sarcoidosis Vasc Diffuse Lung Dis. 2001 Jun;18(2):170-5.
4
The 1-min sit-to-stand test as a screening tool to assess exercise-induced oxygen desaturation in normoxemic people with interstitial lung disease.1 分钟坐站测试作为一种筛选工具,用于评估常压性间质肺疾病患者运动引起的氧减饱和度。
Respir Med. 2024 Oct;232:107748. doi: 10.1016/j.rmed.2024.107748. Epub 2024 Jul 27.
5
The 1-minute sit-to-stand test to detect exercise-induced oxygen desaturation in patients with interstitial lung disease.1 分钟坐站测试在间质性肺疾病患者中检测运动诱导的氧减饱和。
Ther Adv Respir Dis. 2018 Jan-Dec;12:1753466618793028. doi: 10.1177/1753466618793028.
6
Should oxyhaemoglobin saturation be monitored continuously during the 6-minute walk test?在 6 分钟步行试验期间是否应该连续监测氧合血红蛋白饱和度?
Chron Respir Dis. 2011;8(3):181-4. doi: 10.1177/1479972311407355.
7
Impact of Real-Time Assessment of Pulse Oximetry on the 6-Min Walk Distance in Patients With Chronic Respiratory Disease.实时脉搏血氧饱和度评估对慢性呼吸疾病患者 6 分钟步行距离的影响。
Respir Care. 2024 Sep 26;69(10):1294-1304. doi: 10.4187/respcare.11751.
8
Six-minute stepper test to assess effort intolerance in interstitial lung diseases.六分钟踏阶试验评估间质性肺疾病中的运动不耐受情况。
Sarcoidosis Vasc Diffuse Lung Dis. 2012 Oct;29(2):107-12.
9
Prognostic value of walk distance, work, oxygen saturation, and dyspnea during 6-minute walk test in COPD patients.慢性阻塞性肺疾病患者 6 分钟步行试验中步行距离、工作、血氧饱和度和呼吸困难的预后价值。
Respir Care. 2013 Aug;58(8):1329-34. doi: 10.4187/respcare.02290. Epub 2013 Jan 15.
10
Exercise-induced oxygen desaturation in COPD patients without resting hypoxemia.运动诱导的 COPD 患者在静息时不伴有低氧血症时的氧减饱和。
Respir Physiol Neurobiol. 2014 Jan 1;190:40-6. doi: 10.1016/j.resp.2013.10.002. Epub 2013 Oct 9.

引用本文的文献

1
Value of the 6 min walk test in detecting cardiopulmonary involvement in patients with systemic sclerosis.6分钟步行试验在检测系统性硬化症患者心肺受累情况中的价值。
RMD Open. 2025 Jul 15;11(3):e005154. doi: 10.1136/rmdopen-2024-005154.
2
The DSC Index: A new prognostic tool for evaluating functional status in interstitial lung disease.DSC指数:一种评估间质性肺疾病功能状态的新预后工具。
Sarcoidosis Vasc Diffuse Lung Dis. 2025 Mar 18;42(1):13949. doi: 10.36141/svdld.v42i1.13949.
3
Evaluation of novel indices of walking performance taking oxygen desaturation into account during six-minute walk test in cardiovascular disease patients.

本文引用的文献

1
Pulmonary manifestations of gastroesophageal reflux disease.胃食管反流病的肺部表现。
Ann Thorac Med. 2009 Jul;4(3):115-23. doi: 10.4103/1817-1737.53347.
2
Walking distance on 6-MWT is a prognostic factor in idiopathic pulmonary fibrosis.6分钟步行试验中的步行距离是特发性肺纤维化的一个预后因素。
Respir Med. 2009 Jan;103(1):117-23. doi: 10.1016/j.rmed.2008.07.022. Epub 2008 Sep 10.
3
HRCT and histopathological evaluation of fibrosis and tissue destruction in IPF associated with pulmonary emphysema.特发性肺纤维化合并肺气肿时纤维化及组织破坏的高分辨率计算机断层扫描(HRCT)与组织病理学评估
评估心血管疾病患者在六分钟步行试验中考虑氧饱和度降低时的新型行走能力指标。
Heart Vessels. 2024 Oct;39(10):877-883. doi: 10.1007/s00380-024-02411-8. Epub 2024 May 12.
4
Usefulness of a new parameter in functional assessment in patients with idiopathic pulmonary fibrosis: desaturation - distance ratio from the six-minute walk test.一项新参数在特发性肺纤维化患者功能评估中的效用:六分钟步行试验的氧饱和度-距离比
Sarcoidosis Vasc Diffuse Lung Dis. 2023 Jun 29;40(2):e2023021. doi: 10.36141/svdld.v40i2.14634.
5
Assessment of Exercise Capacity in Post-COVID-19 Patients: How Is the Appropriate Test Chosen?新冠后患者运动能力评估:如何选择合适的测试?
Life (Basel). 2023 Feb 23;13(3):621. doi: 10.3390/life13030621.
6
Effects of SARS-CoV-2 Infection on Pulmonary Function Tests and Exercise Tolerance.新型冠状病毒2019感染对肺功能测试及运动耐力的影响。
J Clin Med. 2022 Aug 23;11(17):4936. doi: 10.3390/jcm11174936.
7
Desaturation-Distance Ratio During Submaximal and Maximal Exercise Tests and Its Association With Lung Function Parameters in Patients With Lymphangioleiomyomatosis.淋巴管平滑肌瘤病患者次极量和极量运动试验中的去饱和-距离比及其与肺功能参数的关联
Front Med (Lausanne). 2021 Jul 29;8:659416. doi: 10.3389/fmed.2021.659416. eCollection 2021.
8
Usefulness of the desaturation-distance ratio from the six-minute walk test for patients with COPD.六分钟步行试验中去饱和-距离比在慢性阻塞性肺疾病患者中的应用价值
Int J Chron Obstruct Pulmon Dis. 2017 Sep 6;12:2669-2675. doi: 10.2147/COPD.S143477. eCollection 2017.
9
Application of a new parameter in the 6-minute walk test for manifold analysis of exercise capacity in patients with COPD.一种新参数在慢性阻塞性肺疾病患者运动能力多维度分析的6分钟步行试验中的应用。
Int J Chron Obstruct Pulmon Dis. 2014 Nov 3;9:1235-40. doi: 10.2147/COPD.S71383. eCollection 2014.
10
Evaluation of the extent of pulmonary cysts and their association with functional variables and serum markers in lymphangioleiomyomatosis (LAM).淋巴管肌瘤病(LAM)中肺囊肿程度的评估及其与功能变量和血清标志物的关系。
Lung. 2014 Dec;192(6):967-74. doi: 10.1007/s00408-014-9641-2. Epub 2014 Sep 9.
Respir Med. 2008 Dec;102(12):1753-61. doi: 10.1016/j.rmed.2008.07.010. Epub 2008 Aug 23.
4
New reference values for forced spirometry in white adults in Brazil.巴西白人成年人用力肺活量的新参考值。
J Bras Pneumol. 2007 Jul-Aug;33(4):397-406. doi: 10.1590/s1806-37132007000400008.
5
Extraesophageal manifestations of gastroesophageal reflux disease.胃食管反流病的食管外表现
J Bras Pneumol. 2006 Mar-Apr;32(2):150-60. doi: 10.1590/s1806-37132006000200011.
6
Idiopathic pulmonary fibrosis: prognostic value of changes in physiology and six-minute-walk test.特发性肺纤维化:生理学变化及六分钟步行试验的预后价值
Am J Respir Crit Care Med. 2006 Oct 1;174(7):803-9. doi: 10.1164/rccm.200604-488OC. Epub 2006 Jul 6.
7
Six-minute-walk distance predicts waiting list survival in idiopathic pulmonary fibrosis.六分钟步行距离可预测特发性肺纤维化患者在等待名单上的生存情况。
Am J Respir Crit Care Med. 2006 Sep 15;174(6):659-64. doi: 10.1164/rccm.200604-520OC. Epub 2006 Jun 15.
8
Lymphangioleiomyomatosis.淋巴管平滑肌瘤病
Eur Respir J. 2006 May;27(5):1056-65. doi: 10.1183/09031936.06.00113303.
9
The distance-saturation product predicts mortality in idiopathic pulmonary fibrosis.距离-饱和度乘积可预测特发性肺纤维化的死亡率。
Respir Med. 2006 Oct;100(10):1734-41. doi: 10.1016/j.rmed.2006.02.004. Epub 2006 Mar 20.
10
Combined pulmonary fibrosis and emphysema: a distinct underrecognised entity.合并性肺纤维化和肺气肿:一种未被充分认识的独特病症。
Eur Respir J. 2005 Oct;26(4):586-93. doi: 10.1183/09031936.05.00021005.